Maisha Meds provides a mobile app that helps healthcare providers deliver affordable care to patients. The company reimburses pharmacies and clinics for providing subsidized care and offers business management tools through their app.

Maisha Meds

Maisha Meds has created the first and largest network of private pharmacies and clinics in East Africa through a mobile app that delivers subsidized care. Not only does the app now help over 3,500 businesses operate by making sales, managing inventory, and tracking patients; it also reimburses them for providing affordable care to patients for malaria, birth control, and HIV prevention. By harnessing the power of a vast but fragmented private sector, our program improves access for patients, supports pharmacies that often serve as a first point of contact, and generates vital research and data on global health and market trends.

Villgro Kenya

We are hiring! Our reimbursement program is coming to Tanzania 🇹🇿! If you are passionate about public health and have the skills & experience we are looking for, let's talk 😊. #AngukaNayo 😉

It was an honor to host an event this week on differentiated service delivery for HIV PrEP/PEP at the 25th International AIDS Society Conference in Munich, Germany!

Our panelists and presenters brought a wealth of experience and insight on innovating approaches, overcoming barriers, and expanding access to HIV prevention, including:

🚀 Embracing innovative models that leverage the strengths of both the public and private sectors, from community pharmacies to telehealth platforms. A reminder that one size does not fit all.

💉 Being agile in integrating new products like injectables as they become available, while also maximizing the tools we already have to prevent thousands of new HIV infections daily.

📖 Shifting our approach around evidence and policy to better support these innovations, ensuring they reach and empower communities to shape their own health outcomes.

We are immensely grateful to our co-host Children's Investment Fund Foundation (CIFF) and our supporter the Bill & Melinda Gates Foundation, as well as distinguished speakers from The Global Fund, Clinton Health Access Initiative, Inc., USAID/PEPFAR, Division of National AIDS and STI Control Program, Ministry of Health -Kenya, MYDAWA, Jhpiego, and The Wits Reproductive Health and HIV Institut​e (Wits RHI). We are as energized as ever to continue making progress together! 🌍

This Sunday, Maisha Meds is proud to be hosting this #AIDS2024 pre-conference on differentiated service delivery for HIV PrEP & PEP, in partnership with Children's Investment Fund Foundation (CIFF). 

We look forward to seeing you at the 25th International AIDS Conference. More info: mmeds.link/AIDS2024

We are proud to support this new effort with Signalytic, Joint Medical Store, and HETA to digitize and electrify 65 private health facilities in Uganda. Our software will help connect and streamline these locations as part of an initiative bringing solar power and connectivity to last-mile areas that need reliable, cost-effective infrastructure.

See how our prior partnership with HETA in Tanzania increased access to sustainable electricity and digital tools for 250 private-sector facilities: https://lnkd.in/eVf4wrND

When it comes to malaria treatments, what percentage of ACTs do you think are sold in Tanzania’s private sector? 

We asked you in a poll last week, and we're sharing key findings from our ongoing analyses below. 📊

Want to know more? 
—Sign up for our quarterly data report: maishameds.org/data
—View last week's poll: https://lnkd.in/gbzDWhSp

✨ We thank our government and academic partners and look forward to continuing to collaborate and refine our analysis, with the goal of submitting for peer review.

We have been taking a close look at antimalarial markets across Africa's private sector, focusing on the recommended treatments — namely ACTs (artemisinin-based combination therapies).

🔎 Take your best guess below, and check back next week to find out what our latest analysis on Tanzania revealed.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 5, 2024 2:47 PM	16f1d664
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 5, 2024 2:47 PM	47a6f1b6
translate crunchbase fundingrounds	general
peers	general	Aug 5, 2024 2:47 PM	2ccf009f
news basic	general	Aug 5, 2024 2:47 PM	a5f24c21
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ORG:MAISHAMEDS

Maisha Meds